Post

Labcorp launches blood test for neurodegenerative diseases detection

Global life sciences company Labcorp has announced the first commercially available glial fibrillary acidic protein (GFAP) blood biomarker test in …

Paragonix heart transplant trial cuts graft dysfunction by half

US-based organ transplant company, Paragonix, has announced a trial of its SherpaPak organ preservation system saw a 50% reduction in …

IceCure seeks FDA approval for ProSense cryoablation for breast cancer

IceCure Medical has submitted final data to the US Food and Drug Administration (FDA) seeking marketing authorisation for its ProSense …

TELA Bio launches OviTex IHR for inguinal hernia repair in US

Medical technology company TELA Bio has announced the commercial launch of OviTex IHR (Inguinal Hernia Repair) Reinforced Tissue Matrix, a …

3D Systems obtains 510(k) clearance for 3D-printed cranial implants

3D Systems has received 510(k) clearance from the US Food and Drug Administration (FDA) for its VSP PEEK Cranial Implant. The …